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Abstract: The researches were made during 2006-2007 within the Microbiology Laboratory 
of the Faculty of Veterinary Medicine Cluj-Napoca. A number of 23 Malassezia pachydermatis strains 
were tested regarding the sensibility to antifungal products currently used in therapy. The antimycotic 
products were represented by ketoconazole, itraconazole, nystatin and acetic acid. The best efficiency 
was registered for itraconazole, followed by ketoconazole, nystatin and acetic acid. 
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INTRODUCTION 
 
 The genus Malassezia is known to include thirteen species of yeasts, many of which 
have been associated with various diseases in worm blooded vertebrates. Malassezia 
pachydermatis is a lipophilic budding yeast that colonizes the skin and mucosal sites of 
healthy dogs (1,2). Despite being part of the normal cutaneous micro flora, it is known that 
the yeast may become pathogen under certain circumstances (1,3). Malassezia dermatitis, an 
inflammatory dermatitis associated with elevated populations of M. pachydermatis on the skin 
of dogs, has been recognized with increased frequency (2,3).  
 The microscopic appearance of Malassezia pachydermatis is oval to peanut-shaped 
and is approximately 2-3 µm in width and 4-5 µm in length. Colonies are medium sized, 
round and convex shaped, white-yellow colored, developed on solid environments in 5-7 
days. Reproduction is asexually achieved by unipolar or sympodial (M. sympodialis) budding 
(1,4).  
Unlike many bacteria or other fungi, Malassezia yeasts are rarely found in the 
environment. Their habitat is primarily the skin and mucosa of mammals and birds. In healthy 
dogs, M. pachydermatis can be isolated from the ear channel, anus, rectum, oral cavity and, 
less commonly, the nose and vagina. On the normal canine skin, carriage of the yeast is most 
common in the interdigital areas and around the mouth but uncommon on the axilla or dorsum 
(1,5). In other species, Malassezia organisms have been recovered from the skin of healthy 
cats, ferrets, foxes, bears, pigs, horses, birds and rhinoceroses. 
The researches aimed to evaluate “in vitro” efficiency of azole and polyene agents 
(ketoconazole, itraconazole), antifungal (nystatin) and acetic acid on 23 M. pachydermatis 
strains isolated from healthy dogs and dogs with ear and cutaneous lesions. 
 
MATERIAL AND METHODS 
 
 The investigations took place during 2006-2007 within the Microbiology Laboratory 
of the Faculty of Veterinary Medicine Cluj-Napoca. The 23 Malassezia pachydermatis strains 
 322 
tested in the study were isolated from dogs in Cluj-Napoca (14), Bari – Italy (7) and 
Bucharest (2). Each strain was initially suspended in Salina to a density of 0,5 McFarland 
scale, and a 9 cm Petri dish containing Sabouraud agar was flooded. The excess was removed 
and the agar surface dried. Buckets of 3 mm diameter were performed, and the products to be 
tested were placed similar to the antibiograma model. 
  The products tested were the following: 
1. Ketoconazole – is a synthetic antifungal drug to prevent and treat skin and fungal 
infections having wide spectrum for dermatophites (Microsporum, Tricophyton, 
Epidermophyton), yeasts (Candida, Pityrosporum Malassezia, Torulopsis, 
Cryptococcus), unicellular algae (Prototheca), gram positive bacteria 
(Staphylococcus aureus, Staphylococcus epidermidis) and anaerobes. The 
mechanism of action is cell membrane destruction increasing it’s permeability due 
to the direct action and ergosterole biosynthesis inhibition. 
2.   Itraconazole – a triasolic derivate active on dermatophytes, yeasts, fungi and 
unicellular algae. In vitro studies proved that itraconazole is preventing ergosterole 
synthesis in fungi cells, a vital yeast cell membrane component. It is indicated in 
treating candidosis, pitiriazis versicolor, dermatomicosis, criptococosia and other 
systemic mycosis. 
3. Nistatin – is a polienic macrolide having active mechanism on fungi cell 
membrane, forming nystatin channel complex – membramar cholesterol, the loss 
of intracellular ionic constituents and cell death. Is indicated in Candida infections, 
ringworm and pitiriazis.  
4. Acetic acid – a product recommended in the treatment of the otitis produced by 
genus Malassezia yeast, the concentration of the solution being of 2%. The 
recommendations are to be used in association with boric acid. 
After the products were placed, the plates were incubated for 5 days at 32°C. 
 
RESULTS AND DISCUTIONS 
 
From the products tested, the best efficiency was registered for itraconazole, followed 
by ketoconazole and nystatin. Acetic acid determined the appearance of inhibition areas just 
in case of 4 strains isolated from dogs in Cluj-Napoca (strains 7, 12, 25 and 26) and 3 strains 
isolated from Bari (7, 15, and 25).  
 For Itraconazole, sensitive proved to be the strains isolated from Bari and Bucharest 
followed by the strains isolated in Cluj-Napoca. The same situation was registered for 
Ketoconazole and Nystatin.  
 The most sensitive strain to Itraconazole was strain 1 isolated from Bucharest with a 
diameter of the inhibition area of 36 mm. A good sensibility was also registered for the strains 
isolated in Bari, the average of the inhibition area being 31,5, while the strains isolated from 
Cluj-Napoca were less sensitive, with the inhibition area of 17 mm.   
Existed situations when none of the utilized products has any efficiency on the tested 
strains (strain 4 – Cluj-Napoca). In table 1 are presented the number of the strain, 
geographical area of provenience and the diameter of the inhibition areas for each strain and 
product.  
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Table 1 
The results obtained at the products tested (the values represents inhibition area diameter in mm) 
 
Number and strain provenience 
 
Cluj-Napoca 
 
Bucharest 
 
Bari 
 
Used 
product 
4 7 9 10 11 12 15 17 18 20 21 25 26 27 1 3 7 12 15 17 19 25 36 
Ketoconazole 0 12 15 0 17 13 14 13 11 17 14 17 11 18 30 28 28 29 23 26 26 25 28 
Itraconazole 0 17 21 0 23 19 20 18 18 21 20 21 19 23 36 31 32 29 33 37 28 32 30 
Nystatin 0 4 8 8 7 4 5 4 4 8 4 8 5 7 14 13 16 14 11 15 18 12 12 
Acetic acid 0 7 0 0 0 9 0 0 0 0 0 7 6 0 0 0 11 0 13 0 0 9 0 
 
The results obtained for the tested products revealed a very good efficiency of 
Itraconazole, Ketoconazole and Nystatin, while acetic acid had a reduced capacity of 
inhibiting the development of the yeasts from genus Malassezia. 
The two strains from Bucharest tested with antimycotic substances proved to be very 
sensitive to Ketoconazole, with diameters of inhibition areas of 30 and respectively 28 mm, 
for Itraconazole of 36 and 31 mm, for Nystatin of 14 respective 13 mm, while acetic acid had 
no efficiency in case of the strains isolated from Bucharest.  
The representation of the average area diameter for the strains isolated from Cluj-
Napoca, Bucharest and Bari for the tests of the efficiency of the products is represented in 
chart 1:  
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Chart 1. Comparative representation of the average efficacy of the products 
tested in three geographical areas 
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According to the data published by Pinchbeck and col., 2002, itraconazole (azole 
group), has the best efficiency in the treatment of the otitis and dermatitis caused by 
Malassezia pachydermatis, data similar to the results obtained in this study (4).  
Brito and col., 2007, are mentioning that from 34 M. pachydermatis tested strains, all 
presented sensitivity to Itraconazole while 29 were sensitive to Ketoconazole (1). 
 
CONCLUSIONS 
 
1. From the antimycotic products tested, the highest efficiency was registered for 
itraconazole, followed by ketoconazole, nystatin and acetic acid.  
2. Reported to the geographical area of strains provenience, the order of strains sensitivity 
was Bari, Bucharest and respectively Cluj-Napoca, area where the 14 tested strains 
presented the lowest sensitivity to the products tested.  
3. In case of two strains isolated from Cluj-Napoca, strain 4 proved to be resistant to all the 
products tested, while strain number 10 presented moderate sensitivity to nystatin (8 mm).  
4. The average of the inhibition area registered for the antimycotic products in case of the 
strains isolated from Cluj-Napoca registered the lowest values, being of 12,28 mm for 
ketoconazole, 17,14 mm for itraconazole, 5,42 mm for nystatin, respectively 2,07 mm for 
acetic acid. 
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